Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's, and doesn't require supercold temperature
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19—and it has several advantages over those of its competitors, Pfizer and Moderna.
Nov 25, 2020
0
3